• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

特发性肺纤维化患者的气体陷闭:一项回顾性病例对照研究。

Air trapping in patients with idiopathic pulmonary fibrosis: a retrospective case-control study.

作者信息

Kim Taehun, Kim Mi-Ae, Youn Seong Hwan, Kwon Yongshik, Kim Hyun Jung, Park Jae Seok, Park Sun Hyo

机构信息

Division of Pulmonary Medicine, Department of Internal Medicine, Keimyung University Dongsan Medical Center, 1035, Dalgubeol-daero, Dalseo-gu, Daegu, 42601, South Korea.

出版信息

Sci Rep. 2025 Feb 24;15(1):6670. doi: 10.1038/s41598-025-91060-6.

DOI:10.1038/s41598-025-91060-6
PMID:39994366
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11850588/
Abstract

Idiopathic pulmonary fibrosis (IPF) is characterised by progressive worsening of lung function. In some cases, IPF is accompanied by air-trapping and emphysema. This study aimed to evaluate air trapping quantified with RV/TLC in patients with IPF. This retrospective study included 122 patients diagnosed with IPF in South Korea between January 2011 and December 2020. Air trapping was defined as RV/TLC ≥ 0.40. Increased RV/TLC was found in 34.4% of all patients. The RV/TLC negatively correlated with lung function (forced expiratory volume in 1 s and functional vital capacity [FVC]) and showed consistent results after 1 year of follow-up. After propensity score matching, FVC and diffusion capacity between the groups showed no statistical difference. No difference in lung function decline was found between the increased and not increased RV/TLC groups. Regarding univariable analysis, the patients in the increased RV/TLC group had a lower risk of all-cause mortality (hazard ratio 1.753, P = 0.034). Using multivariable analysis, age, pirfenidone treatment, and FVC were significant factors for survival but not increased RV/TLC. Increased RV/TLC was related to emphysema and demonstrated a negative relationship with lung function. Although increased RV/TLC might relate to poor clinical outcome, it was not independent prognostic factor for IPF.

摘要

特发性肺纤维化(IPF)的特征是肺功能进行性恶化。在某些情况下,IPF伴有气体潴留和肺气肿。本研究旨在评估通过残气量/肺总量(RV/TLC)量化的IPF患者的气体潴留情况。这项回顾性研究纳入了2011年1月至2020年12月期间在韩国诊断为IPF的122例患者。气体潴留定义为RV/TLC≥0.40。在所有患者中,34.4%发现RV/TLC升高。RV/TLC与肺功能(第1秒用力呼气量和功能肺活量[FVC])呈负相关,并且在随访1年后结果一致。倾向得分匹配后,两组之间的FVC和弥散能力无统计学差异。RV/TLC升高组和未升高组之间的肺功能下降无差异。单因素分析显示,RV/TLC升高组患者的全因死亡率风险较低(风险比1.753,P = 0.034)。多因素分析显示,年龄、吡非尼酮治疗和FVC是生存的重要因素,但RV/TLC升高不是。RV/TLC升高与肺气肿有关,并且与肺功能呈负相关。虽然RV/TLC升高可能与不良临床结局有关,但它不是IPF的独立预后因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a80/11850588/136000d4d67a/41598_2025_91060_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a80/11850588/1fe0008afb5d/41598_2025_91060_Fig1a_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a80/11850588/d46fdfd6535a/41598_2025_91060_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a80/11850588/b5be64986052/41598_2025_91060_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a80/11850588/136000d4d67a/41598_2025_91060_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a80/11850588/1fe0008afb5d/41598_2025_91060_Fig1a_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a80/11850588/d46fdfd6535a/41598_2025_91060_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a80/11850588/b5be64986052/41598_2025_91060_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a80/11850588/136000d4d67a/41598_2025_91060_Fig4_HTML.jpg

相似文献

1
Air trapping in patients with idiopathic pulmonary fibrosis: a retrospective case-control study.特发性肺纤维化患者的气体陷闭:一项回顾性病例对照研究。
Sci Rep. 2025 Feb 24;15(1):6670. doi: 10.1038/s41598-025-91060-6.
2
Influence of radiological emphysema on lung function test in idiopathic pulmonary fibrosis.放射性肺气肿对特发性肺纤维化肺功能检查的影响。
Respir Med. 2013 Nov;107(11):1781-8. doi: 10.1016/j.rmed.2013.08.039. Epub 2013 Sep 3.
3
Phenotypes and Trajectories of Tobacco-exposed Persons with Preserved Spirometry: Insights from Lung Volumes.肺功能正常的烟草暴露者的表型和轨迹:来自肺容量的见解
Ann Am Thorac Soc. 2025 Apr;22(4):494-505. doi: 10.1513/AnnalsATS.202405-527OC.
4
[A comparison of clinical features between patients with idiopathic pulmonary fibrosis combined with emphysema and without emphysema].特发性肺纤维化合并肺气肿与未合并肺气肿患者的临床特征比较
Zhonghua Jie He He Hu Xi Za Zhi. 2013 Mar;36(3):173-6.
5
Quantitative CT analysis of idiopathic pulmonary fibrosis and correlation with lung function study.特发性肺纤维化的定量 CT 分析及其与肺功能研究的相关性。
BMC Pulm Med. 2024 Sep 5;24(1):437. doi: 10.1186/s12890-024-03254-9.
6
Real-life experiences in a single center: efficacy of pirfenidone in idiopathic pulmonary fibrosis and fibrotic idiopathic non-specific interstitial pneumonia patients.单中心真实世界经验:吡非尼酮治疗特发性肺纤维化和特发性非特异性间质性肺炎纤维化患者的疗效。
Ther Adv Respir Dis. 2020 Jan-Dec;14:1753466620963015. doi: 10.1177/1753466620963015.
7
Combined pulmonary fibrosis and emphysema: How does cohabitation affect respiratory functions?合并性肺纤维化和肺气肿:同居如何影响呼吸功能?
Adv Med Sci. 2019 Sep;64(2):285-291. doi: 10.1016/j.advms.2019.03.005. Epub 2019 Apr 1.
8
Efficacy and Safety of Pirfenidone in Advanced Idiopathic Pulmonary Fibrosis.吡非尼酮治疗特发性肺纤维化的有效性和安全性。
Respiration. 2019;97(3):242-251. doi: 10.1159/000492937. Epub 2018 Oct 17.
9
The Prognostic Value of Residual Volume/Total Lung Capacity in Patients with Chronic Obstructive Pulmonary Disease.残气量/肺总量在慢性阻塞性肺疾病患者中的预后价值
J Korean Med Sci. 2015 Oct;30(10):1459-65. doi: 10.3346/jkms.2015.30.10.1459. Epub 2015 Sep 12.
10
Pirfenidone in patients with idiopathic pulmonary fibrosis and more advanced lung function impairment.吡非尼酮治疗特发性肺纤维化伴更严重肺功能损害的患者。
Respir Med. 2019 Jul;153:44-51. doi: 10.1016/j.rmed.2019.04.016. Epub 2019 Apr 24.

本文引用的文献

1
Improved Survival of IPF patients Treated With Antifibrotic Drugs Compared With Untreated Patients.与未治疗的患者相比,接受抗纤维化药物治疗的特发性肺纤维化患者的生存率提高。
Lung. 2023 Aug;201(4):335-343. doi: 10.1007/s00408-023-00628-4. Epub 2023 Jun 21.
2
Impact of body weight change on clinical outcomes in patients with idiopathic pulmonary fibrosis receiving pirfenidone.体重变化对接受吡非尼酮治疗的特发性肺纤维化患者临床结局的影响。
Sci Rep. 2022 Oct 17;12(1):17397. doi: 10.1038/s41598-022-22449-w.
3
Idiopathic Pulmonary Fibrosis (an Update) and Progressive Pulmonary Fibrosis in Adults: An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline.
特发性肺纤维化(更新版)和成人进展性肺纤维化:美国胸科学会/欧洲呼吸学会/日本呼吸学会/拉丁美洲胸科学会临床实践指南。
Am J Respir Crit Care Med. 2022 May 1;205(9):e18-e47. doi: 10.1164/rccm.202202-0399ST.
4
Air Trapping and the Risk of COPD Exacerbation: Analysis From Prospective KOCOSS Cohort.气体陷闭与慢性阻塞性肺疾病急性加重风险:来自前瞻性KOCOSS队列的分析
Front Med (Lausanne). 2022 Mar 11;9:835069. doi: 10.3389/fmed.2022.835069. eCollection 2022.
5
ERS/ATS technical standard on interpretive strategies for routine lung function tests.ERS/ATS 技术标准:常规肺功能测试的解释策略。
Eur Respir J. 2022 Jul 13;60(1). doi: 10.1183/13993003.01499-2021. Print 2022 Jul.
6
Clinical impact of long-term change in air trapping on pulmonary function and computed tomography parameters in chronic obstructive pulmonary disease.慢性阻塞性肺疾病中空气潴留的长期变化对肺功能和计算机断层扫描参数的临床影响。
Korean J Intern Med. 2021 May;36(3):636-646. doi: 10.3904/kjim.2019.425. Epub 2020 Nov 25.
7
Acute exacerbations of COPD versus IPF in patients with combined pulmonary fibrosis and emphysema.合并性肺纤维化和肺气肿患者的 COPD 急性加重与 IPF 。
Respir Res. 2020 Jun 30;21(1):164. doi: 10.1186/s12931-020-01432-x.
8
The European MultiPartner IPF registry (EMPIRE): validating long-term prognostic factors in idiopathic pulmonary fibrosis.欧洲多伙伴特发性肺纤维化注册研究(EMPIRE):验证特发性肺纤维化的长期预后因素。
Respir Res. 2020 Jan 8;21(1):11. doi: 10.1186/s12931-019-1271-z.
9
Korean Guidelines for Diagnosis and Management of Interstitial Lung Diseases: Part 2. Idiopathic Pulmonary Fibrosis.韩国间质性肺疾病诊断与管理指南:第2部分。特发性肺纤维化
Tuberc Respir Dis (Seoul). 2019 Apr;82(2):102-117. doi: 10.4046/trd.2018.0091. Epub 2019 Feb 28.
10
Air trapping in usual interstitial pneumonia pattern at CT: prevalence and prognosis.CT 上常见间质性肺炎模式的空气潴留:患病率和预后。
Sci Rep. 2018 Nov 22;8(1):17267. doi: 10.1038/s41598-018-35387-3.